Biotest GmbH KGaA (LTS:0N6Z) Total Equity: £0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biotest GmbH KGaA Total Equity?

Biotest GmbH KGaA LTS:0N6Z Total Equity is £0.00 Mil as of . 20.

Biotest GmbH KGaA's total equity for the quarter that ended in . 20 was £0.00 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Biotest GmbH KGaA Total Equity Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA Total Equity Chart

Biotest GmbH KGaA Annual Data
Trend
Total Equity

Biotest GmbH KGaA Semi-Annual Data
Total Equity

Biotest GmbH KGaA Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Biotest GmbH KGaA's Total Equity for the fiscal year that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

Biotest GmbH KGaA's Total Equity for the quarter that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of £0.00 Mil mean?
Biotest GmbH KGaA (LTS:0N6Z) has a Total Equity of £0.00 Mil as of . 20. The total amount of equity as record on a company's balance sheet. View historical data for Biotest GmbH KGaA and its competitors.
Is Biotest GmbH KGaA's Total Equity too high?
Biotest GmbH KGaA's current Total Equity is £0.00 Mil.
How does Biotest GmbH KGaA's Total Equity compare to ?
Biotest GmbH KGaA's Total Equity of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Biotest GmbH KGaA and its competitors. Biotest GmbH KGaA's current Total Equity is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest GmbH KGaA stock overvalued right now?
Biotest GmbH KGaA (LTS:0N6Z) has a current Total Equity of £0.00 Mil. The current Total Equity is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Biotest GmbH KGaA (LTS:0N6Z), the current Total Equity is £0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.